Metaage Stock

Metaage ROE

The Return on Equity (ROE) of Metaage (6112.TW) as of Aug 12, 2026 is 7.96 %. In the previous year, Return on Equity (ROE) was 2.79 % — a change of 185.44% (higher).

ROE

7.96 %

YoY

185.44%

Last updated:

In 2026, Metaage's return on equity (ROE) was 7.96 %, a 185.44% increase from the 2.79 % ROE in the previous year.

Access this data via the Eulerpool API

Metaage Stock analysis

What does Metaage do? The Metaage Corp is an innovative company based in San Francisco that specializes in the development of technologies for cognitive aging research. The company was founded in 2016 by a team of experts from various fields, such as science, medicine, and technology. The idea for the founding of Metaage Corp arose from the growing awareness of the impact of demographic change on society. The company aims to develop technologies that help older people maintain their cognitive health and make aging a positive experience. The business model of Metaage Corp is based on a broad research and development strategy that includes the development of new products and technologies for use in various fields. The company is divided into several divisions, including the division for medical devices, the division for software applications, and the division for data analysis. The medical devices of Metaage Corp are aimed at the health and well-being of older people. This includes a wide range of products, such as smart pillows that improve sleep and reduce the risk of falls, as well as wearable devices that enable continuous monitoring of health parameters, such as blood pressure and heart rate. The software applications of Metaage Corp are aimed at improving the cognitive abilities of older people. This includes a range of games and exercises that activate the brain and increase cognitive performance in a playful way. The data analysis department of Metaage Corp specializes in the collection and analysis of medical and health-related data. The company works closely with medical institutions and researchers to understand and analyze the effects of aging and age-related diseases on cognitive health. The offering of Metaage Corp is complemented by a series of training sessions and courses aimed at medical professionals, researchers, and health organizations. The training aims to deepen understanding of the latest developments in aging research and contribute to the development of appropriate treatment options and therapies. Metaage Corp has become a key player in aging research and is supported by numerous researchers and medical professionals. The company aims to meet the challenges of demographic change with innovative and advanced technologies and products and contribute to making the lives of older people more positive. Metaage is one of the most popular companies on Eulerpool.

ROE Details

Decoding Metaage's Return on Equity (ROE)

Metaage's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Metaage's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Metaage's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Metaage’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Metaage stock

Return on Equity (ROE) of Metaage is 7.96 % in 2026.

Return on Equity (ROE) of Metaage changed from 2.79 % to 7.96 %, representing a 185.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Metaage since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Metaage with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Metaage

All Key Metrics — Metaage